28080

28080
Arrieta A, Hong J, Khera R, et al. Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial. JAMA Cardiol; 2017. 2(12):1369–1374. DOI: 10.1001/jamacardio.2017.3655. http://www.ncbi.nlm.nih.gov/pubmed/29049467.
Einstellungen
28080
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 05.08.2022 | 10:01 Uhr